Reduced CTLA4 or TNFAIP3 (A20) function increases autoimmune susceptibility.

CTLA4 and TNFAIP3 (A20) are critical regulatory "brakes" that maintain immune homeostasis. Evidence confirms that genetic or functional impairments in these pathways significantly weaken the body's ability to resolve inflammation and maintain self-tolerance, particularly in the aftermath of an infection.

Mechanistic Role of Immune "Brakes"

• CTLA4 (T-cell Regulation): CTLA-4 is a high-affinity receptor that outcompetes the costimulatory molecule CD28 for binding to B7 ligands on antigen-presenting cells. By sequestering these ligands, CTLA-4 prevents the "Signal 2" required for T-cell activation. It also actively removes these ligands via trans-endocytosis, effectively raising the threshold for T-cell signaling.
• TNFAIP3/A20 (NF-κB Regulation): A20 acts as a master regulator of the NF-κB pathway. It utilizes dual ubiquitin-editing functions to remove activating ubiquitin chains from signaling proteins (like RIP1 and TRAF6) and add degradative chains. This action terminates inflammatory signaling triggered by TNF-α or toll-like receptors (TLRs).

Impact of Reduced Function and Infection

• Tolerance Breakdown: Variants such as the CTLA4 rs3087243 (G allele) and TNFAIP3 rs6920220 risk alleles reduce the expression or stability of these proteins. This "leaky" brake system means the immune system cannot efficiently return to a quiescent state after being triggered by a pathogen.
• The Post-Infection Trigger: Infections like Epstein-Barr Virus (EBV) provide strong inflammatory stimuli. In individuals with reduced CTLA4 or A20 function, the immune system fails to dampen the response post-infection. This leads to chronic lymphocyte activation and the survival of self-reactive cells that would normally be suppressed or deleted.
• Autoimmune Susceptibility: This failure to restore tolerance is a primary driver of autoimmune susceptibility. Reduced CTLA4 function is strongly linked to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), while A20 haploinsufficiency (HA20) results in early-onset autoinflammatory syndromes and increased risk for inflammatory bowel disease (IBD).

Bottom line

The claim is strongly supported by science. CTLA4 and TNFAIP3 are essential molecular brakes; when their function is reduced, the immune system cannot properly "reset" after an infection, leading to a persistent state of hyper-activation that increases the risk of developing autoimmune diseases.